Kindred Biosciences is a biopharmaceutical company that specializes in developing therapeutic treatments for pets. The company's product pipeline includes small molecules and biologics for a wide range of medical conditions in dogs, cats, and horses. Some of its products include Mirataz, a weight loss management ointment for cats, and Zimeta IV and Zimeta Oral, which help control fever in horses. Additionally, the company is working on developing monoclonal antibodies for various conditions such as atopic dermatitis, gastric ulcers, and inflammatory bowel disease in canines. Kindred Biosciences was founded in 2012 and is based in Burlingame, California.
Kindred Biosciences Inc's ticker is KIN
The company's shares trade on the ASX stock exchange
They are based in Osborne Park, Australia
There are 11-50 employees working at Kindred Biosciences Inc
It is https://kindredbio.com/
Kindred Biosciences Inc is in the Basic Materials sector
Kindred Biosciences Inc is in the Gold industry
The following five companies are Kindred Biosciences Inc's industry peers: